Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
复制标题
DOI:
10.3390/molecules26071981
复制
发表时间:
2021-04-01
期刊:
影响因子:
--
通讯作者:
Reddy MM
中科院分区:
文献类型:
--
作者:
Borah NA;Reddy MM
Aurora kinase B (AURKB) is a mitotic serine/threonine protein kinase that belongs to the aurora kinase family along with aurora kinase A (AURKA) and aurora kinase C (AURKC). AURKB is a member of the chromosomal passenger protein complex and plays a role in cell cycle progression. Deregulation of AURKB is observed in several tumors and its overexpression is frequently linked to tumor cell invasion, metastasis and drug resistance. AURKB has emerged as an attractive drug target leading to the development of small molecule inhibitors. This review summarizes recent findings pertaining to the role of AURKB in tumor development, therapy related drug resistance, and its inhibition as a potential therapeutic strategy for cancer. We discuss AURKB inhibitors that are in preclinical and clinical development and combination studies of AURKB inhibition with other therapeutic strategies.
登录
查看更多内容
影响因子:
50.5
作者:
Boss, D. S.;Witteveen, P. O.;Schellens, J. H.
通讯作者:
Schellens, J. H.
影响因子:
--
作者:
Bogen D;Wei JS;Azorsa DO;Ormanoglu P;Buehler E;Guha R;Keller JM;Mathews Griner LA;Ferrer M;Song YK;Liao H;Mendoza A;Gryder BE;Sindri S;He J;Wen X;Zhang S;Shern JF;Yohe ME;Taschner-Mandl S;Shohet JM;Thomas CJ;Martin SE;Ambros PF;Khan J
通讯作者:
Khan J
DOI:
10.1083/jcb.153.4.865
发表时间:
2001-05-14
期刊:
The Journal of cell biology
影响因子:
--
作者:
Adams RR;Maiato H;Earnshaw WC;Carmena M
通讯作者:
Carmena M
影响因子:
3.7
作者:
Illert AL;Seitz AK;Rummelt C;Kreutmair S;Engh RA;Goodstal S;Peschel C;Duyster J;von Bubnoff N
通讯作者:
von Bubnoff N
影响因子:
7.3
作者:
Adams, Nicholas D.;Adams, Jerry L.;Dhanak, Dashyant
通讯作者:
Dhanak, Dashyant